National Priority Voucher Program
The FDA has announced the first nine companies to participate in its National Priority Voucher program, which aims to promote novel treatments that benefit the health interests of Americans.
This includes medications that meet a large, unmet need or reduce downstream health care utilization, as well as those that utilize MFN pricing.
The Priority Voucher program is a new initiative at the agency to promote novel treatments that FDA believes will benefit the health interests of Americans.
Nine medications are on the initial list of program participants.
Author's summary: FDA announces participants in National Priority Voucher program.
More News
- Golden State Warriors vs Cleveland Cavaliers regular season game: Full injury report, who's out, and more
- Solidarity on Trial in Greece
- Is London The Top City In The World For This Cuisine? These Chefs Say Yes
- Oil spills and technological cooperation for their prevention
- Spillcontrol – Spill Control
- Warriors 99-94 Cavaliers (Dec 6, 2025) Game Recap
- Netanyahu: Won’t quit politics for pardon in corruption trial
- Golden State Warriors vs Cleveland Cavaliers | Live Play-By-Play & Reactions
- The first week of testimony in Brian Walshe’s murder trial is over. Here are takeaways from Day 5
- Where the Chefs Eat: Skye McAlpine’s Venice